Seeing Is Believing: The Gene Therapy Breakthrough Thats Giving Sight to the Blind SciTechDaily
See original here:
Seeing Is Believing: The Gene Therapy Breakthrough Thats Giving Sight to the Blind - SciTechDaily
VisiActive Review: The Natural Approach to Enhancing Your Vision and Eye Care Bellevue Reporter
Read the original:
VisiActive Review: The Natural Approach to Enhancing Your Vision and Eye Care - Bellevue Reporter
Does VisiActive Work? An Honest Review of Its Eye Health Claims Kirkland Reporter
View post:
Does VisiActive Work? An Honest Review of Its Eye Health Claims - Kirkland Reporter
Sharp eye test: Only those with a perfect vision can spot the third dog in the picture The Times of India
Does X Vision Really Work? An Honest Review of Its Eye Health Benefits Islands' Sounder
Original post:
Does X Vision Really Work? An Honest Review of Its Eye Health Benefits - Islands' Sounder
VisiActive Review: Is This the Ultimate Supplement for Clearer, Healthier Vision? Vashon-Maury Island Beachcomber
Read more here:
VisiActive Review: Is This the Ultimate Supplement for Clearer, Healthier Vision? - Vashon-Maury Island Beachcomber
New Report Recommends Myopia Be Classified as a Disease, Policies for Children to Spend Time Outdoors National Academies of Sciences, Engineering, and Medicine
X Vision Review: How Effective Is This Supplement for Enhancing Vision and Eye Health? Kirkland Reporter
See the original post here:
X Vision Review: How Effective Is This Supplement for Enhancing Vision and Eye Health? - Kirkland Reporter
Elon Musk's Neuralink is working on a product called Blindsight that can restore vision: story in 5 points India Today
View original post here:
Elon Musk's Neuralink is working on a product called Blindsight that can restore vision: story in 5 points - India Today
How the eyes are windows into our health and why we should get them tested South China Morning Post
Read the rest here:
How the eyes are windows into our health and why we should get them tested - South China Morning Post
UK research finds lower rate of GOS sight test activity in areas of deprivation AOP
Here is the original post:
UK research finds lower rate of GOS sight test activity in areas of deprivation - AOP
Dudley residents urged to keep an eye on their optic health Dudley News
View post:
Dudley residents urged to keep an eye on their optic health - Dudley News
Test your eyesight: Find the odd red plane in under 7 seconds The Times of India
Read more from the original source:
Test your eyesight: Find the odd red plane in under 7 seconds - The Times of India
You have 20/20 vision if you can find the hidden chick amongst these ducks IndiaTimes
Follow this link:
You have 20/20 vision if you can find the hidden chick amongst these ducks - IndiaTimes
How to watch the solar eclipse without damaging your eyesight WATE 6 On Your Side
See the rest here:
How to watch the solar eclipse without damaging your eyesight - WATE 6 On Your Side
Can Optical Illusions Improve Vision? Know The Best One That Benefits Eyesight Times Now
Go here to read the rest:
Can Optical Illusions Improve Vision? Know The Best One That Benefits Eyesight - Times Now
FORT LAUDERDALE, Fla. , April 13, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company focused on improving endoscopic outcomes and experiences, today announced executive changes and restructuring as part of its strategy to reduce operating costs while supporting key value creation drivers, including ongoing R&D efforts to bring Pure-Vu Upper GI, and an enhanced Lower GI platform to market, while continuing to support existing customer base and target pipeline opportunities in contracted health systems. As part of the executive changes, Mr. Moran has elected to step down as Chief Executive Officer (CEO) of the Company to pursue other business opportunities. Mr. Moran will remain on the Board and has been appointed Chairman of the Board, succeeding David Hochman, who will remain an independent director, effective immediately. Mark Pomeranz, the Company’s current President, Chief Operating Officer, and director and former CEO of the Company, has been appointed as the Company’s CEO, effective immediately. Mr. Moran will work closely with Mr. Pomeranz to support a smooth transition and maintain key relationships with Motus GI’s stakeholders.
Continue reading here:
Motus GI Announces Executive Leadership Restructuring and Additional Cost Saving Initiatives to Support Near-Term Milestones
REDWOOD CITY, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will be the featured speaker in a fireside chat at the 22nd Annual Needham Healthcare Conference. The conference will take place April 17-20, 2023.
Go here to see the original:
Revolution Medicines to Participate in 22nd Annual Needham Healthcare Conference
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 13, 2023 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with severe chronic liver diseases characterized by high unmet medical needs, today announced annual financial results for the year ended December 31, 2022. A summary of the consolidated financial statements is included further below.
Excerpt from:
GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update
WINNIPEG, Manitoba, April 13, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will announce its fourth quarter and full year 2022 financial results after market close on Thursday, April 20, 2023.
See the article here:
Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow